Evidence map›Paper›PMID 35432586›Full record

ArticleComputational and mathematical methods in medicine2022

An Inhibitor of Nuclear Factor-Kappa B Pathway Attenuates the Release of TGF-

Peng Chen, Xiaoxia Wang, Yanping Li, Hong Liu

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Peng ChenDepartment of Respiratory Medicine, The Third People Hospital of Chengdu, Chengdu, Sichuan 610031, China.
Xiaoxia WangDepartment of Respiratory Medicine, The Third People Hospital of Chengdu, Chengdu, Sichuan 610031, China.
Yanping LiDepartment of Respiratory Medicine, The Third People Hospital of Chengdu, Chengdu, Sichuan 610031, China.
Hong LiuDepartment of Radiology, The Third People Hospital of Chengdu, Chengdu, Sichuan 610031, China.ORCID https://orcid.org/0000-0002-2421-0155
Third People's Hospital of Chengdu · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Airway inflammation, airway hypersecretion, and airway remodeling are believed to be involved in the process of lung fibrosis. Nowadays, acrolein is widely used to establish the model of airway remodeling. An active component of propolis, named caffeic acid phenethyl ester (CAPE), is recognized as an inhibitor of the NF-

Indexed as

AcroleinNF-kappa BAirway RemodelingAnimalsInflammationMiceTransforming Growth Factor beta1AcroleinNF-kappa BTransforming Growth Factor beta1

Identifiers

PMID35432586
PMCPMC9007674
OpenAlexW4226396993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.